3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Polycystic Ovary Syndrome
7
Neoplasms
6
Breast Neoplasms
6
Vomiting
2
Solid Tumors
2
Skin Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Diabetes Mellitus
2
Weight Gain
1
Venous Thromboembolism
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stem Cell Transplant Complications
1
Skin Toxicity
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pre-Eclampsia
1
Polycythemia Vera
1
Parathyroid Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Nausea
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Interventions
Cinacalcet
3
belinostat
2
Trastuzumab
2
Parathyroidectomy
2
Denosumab
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
evocalcet
1
entinostat
1
acetaminophen, codeine drug combination
1
Tramadol
1
Tablets
1
Standard of Care
1
Sodium Chloride
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Immunotherapy
1
Gefitinib
1
Fluorouracil
1
Drug Therapy
1
Dacarbazine
1
Control Groups
1
Congresses as Topic
1
Capsules
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Parathyroid Neoplasms
×
Tablets
×
Clear all
NCT03027557
2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3
Completed
46 enrolled
49 charts